Hernia mesh products are medical devices used to repair hernias — conditions where an organ or tissue bulges through a weak spot in muscle or connective tissue. Surgeons implant synthetic mesh to reinforce the area, allowing tissue to grow into and integrate with the mesh. These medical implants are commonly used in inguinal, ventral, umbilical, and incisional hernia repairs. Surgical manufacturers promoted these implants as safe and reliable, promising better patient outcomes and faster recoveries.
However, serious health complications soon emerged with certain synthetic hernia mesh devices. Patients across Canada and worldwide reported chronic pain, infection, mesh migration, and repeat surgeries. These reports raised questions about whether manufacturers had adequately tested their products or warned about known risks. In many cases, device recalls, safety advisories, and post-market reviews revealed that some hernia mesh products may have been rushed to market without sufficient clinical evidence.
Thousands of patients have reported complications with certain hernia mesh devices, such as hernia recurrence, chronic or acute abdominal pain, bulging near the repair site, mesh migration or erosion, scarring, infection, intestinal blockage, fistula formation, and organ perforation. These complications have been documented across various brands and product lines, particularly involving synthetic or composite mesh materials known to degrade or fail over time.
“Many of our clients have alleged devastating complications from hernia mesh implants — from chronic pain, infection, and scarring to mesh migration, erosion, and hernia recurrence,” explains Jill McCartney, a partner at Siskinds LLP. “These adverse events often require further surgeries and can leave individuals facing lasting discomfort and a diminished quality of life.”
The reported injuries are often linked to defects in mesh design, materials, or manufacturing—such as shrinking, tearing, or inadequate fixation. Many patients required revision surgeries, some suffering lasting pain, disability, or psychological distress. Because of the severity of these hernia mesh injuries, many individuals have sought ongoing medical care, second opinions, or specialist intervention to manage chronic symptoms. In addition, patients experiencing complications have also considered their legal options.
Growing evidence from patient complaints, medical reports, and registry data revealed clear and troubling patterns of device failure among specific hernia mesh products. Of note, Health Canada issued a 2016 safety alert for Ethicon’s Physiomesh Flexible Composite Mesh after registry data showed high recurrence and reoperation rates, prompting a product recall. These findings highlighted serious risks associated with defective hernia mesh and raised concerns about long-term patient safety.
Siskinds LLP began investigating claims for affected Canadians, gathering comprehensive medical evidence and expert analysis on mesh performance and design. The firm filed proposed class actions in multiple provinces against major manufacturers including Ethicon, Bard, Atrium, and Covidien, alleging design defects, failure to warn, and negligence in testing and monitoring. These legal actions aim to hold manufacturers accountable and secure compensation for patients suffering complications.
The national hernia mesh class actions aim to protect Canadians implanted with certain recalled or defective mesh products who suffered serious complications post-surgery. Siskinds, a leader in product liability and medical device litigation, seeks to hold global manufacturers accountable.
The hernia mesh class actions are designed to help affected patients seek compensation for a range of physical, financial, and emotional harms, including:
Beyond compensation for injured patients, Siskinds also aims to promote transparency and stronger regulation in the medical device industry.
To qualify as a class member within one of the surgical mesh cases, Canadians must identify that their implants match products included in the class actions. “To determine whether someone qualifies as a class member, we first need to identify the exact hernia mesh used in their surgery,” explains lawyer Jill McCartney. “That often means obtaining hospital and surgical records, reviewing operative reports, and, if necessary, contacting the implanting surgeon to confirm the product details.”
Hernia mesh litigation in North America has led to significant progress, highlighting the accountability of medical device manufacturers.
Siskinds lawyer James Boyd notes, “The resolution of the Canadian Physiomesh litigation represents an important step forward for Canadian patients who have endured years of suffering because of defective medical products,” adding, “It reinforces the principle that manufacturers must be held to account when their devices cause harm.”
In the U.S., Becton Dickinson (BD) announced a settlement in 2024 to resolve about 38,000 Bard Hernia Mesh lawsuits, expected to result in hundreds of millions of patients. These lawsuits also involve claims of serious complications including mesh migration, adhesion, organ perforation, chronic pain, and the need for additional corrective surgeries.
Siskinds continues to actively pursue other Canadian hernia mesh class actions, representing patients who have suffered complications from various defective mesh products. These lawsuits are progressing toward certification hearings, seeking further court awards or negotiated settlements. Through rigorous legal representation and continued litigation efforts, Siskinds is committed to advancing patient safety, ensuring that victims of hernia mesh complications have a voice.
Medical device manufacturers have a legal and ethical duty to ensure their products are safe, tested, and honestly marketed. When they fail, consequences for patients can be devastating. Ensuring product safety is not just a regulatory requirement, it is a moral obligation to protect patient health.
Defective hernia mesh cases reveal how poor design, testing, and disclosure can lead to lasting harm. Without transparency, physicians cannot advise properly, and patients cannot give informed consent. This lack of disclosure puts patients at risk and undermines trust in the healthcare system. These cases underscore the need for corporate accountability and stricter oversight.
“Accountability in the medical device industry is essential to rebuilding public trust and driving systemic improvements in safety standards,” says Mr. Boyd. “Class actions like the hernia mesh litigation send a clear message: companies must be held responsible when they are negligent with respect to patient safety.”
“We believe many Canadians were implanted with defective hernia mesh products and suffered serious complications, making them potential members of these class actions,” says Ms. McCartney. If you or someone you know was harmed by surgical mesh, email us at [email protected], or contact us by phone at 519.672.2121 or toll free 1.800.461.6166 for a free consultation. Our experienced legal team is here to help you understand your rights and explore your options for compensation. We provide personalized guidance, review your case carefully, and ensure you receive the support you need during this challenging time.
Complete the form on the Hernia Mesh class action page to subscribe to our database and receive all updates and notices regarding this class action.